New insights into the structure of organic-inorganic hybrid perovskites

Movie showing the 3D crystal structure as a function of the cell modulation phase. (grey: Pb, brown: Br, black: C, blue: N; white: H) © HZB

10.00 s

In photovoltaics, organic-inorganic hybrid perovskites have made a rapid career. But many questions about the crystalline structure of this surprisingly complex class of materials remain unanswered. Now, a team at HZB has used four-dimensional modelling to interpret structural data of methylammonium lead bromide (MAPbBr3), identifying incommensurable superstructures and modulations of the predominant structure. The study is published in the ACS Journal of Physical Chemistry Letters and was selected by the editors as an Editor's Choice.

Organic-inorganic hybrid perovskites have been intensively investigated for use in solar cells for about ten years. Thin films of such perovskites are inexpensive and already achieve high efficiencies. In addition, they can be perfectly combined with common solar cell materials such as silicon to form tandem cells. At the beginning of 2020, an HZB team was able to achieve a world record efficiency of 29.15 % with a tandem cell made of perovskite and silicon.

But despite the most intensive research, it has not yet been possible to precisely elucidate the crystal structures with their diverse modulations and superstructures as a function of temperature, even for the best-known perovskite compounds such as methylammonium and formamidinium lead halide. 

Now, a team at HZB has analysed structural data of methylammonium lead bromide (MAPbBr3) with a novel model. Postdoc Dr. Dennis Wiedemann used a model that takes a fourth dimension into account in addition to the three spatial dimensions. The structural data were measured at a temperature of 150 Kelvin at the University of Columbia.

"The problem in these hybrid perovskites is the fact that the different modifications do not differ significantly in energy, so that even small temperature differences are sufficient to trigger phase transitions," explains Dr. Joachim Breternitz, co-author of the study. The data on the crystal structure therefore show an average value over many elementary cells, so that modulations and superstructures are not always recognisable. The new model explains the incommensurable superstructures observed in MAPbBr3 in a small temperature window around 150 K, which do not have the same periodicity as the crystal lattice. This complex structure comes from tilts and shifts in the crystal structure. "The new model will also provide more detailed insights into the modulated structures of other perovskite compounds," says Breternitz.

arö

  • Copy link

You might also be interested in

  • Catalysis research at HZB gets new facility
    News
    06.03.2026
    Catalysis research at HZB gets new facility
    As part of the CatLab project, HZB has acquired a unique facility for measuring the catalytic performance of thin-film catalysts. Built by ILS in Adlershof, it has now been delivered. The facility consists of a total of eight chemical reactors in which catalytic systems can be tested. At over €2.5 million, this is the largest single investment in the CatLab project.
  • Protein crystallography at BESSY II: faster, better and more and more automatic
    Interview
    04.03.2026
    Protein crystallography at BESSY II: faster, better and more and more automatic
    Many diseases are linked to malfunctions of proteins in the organism. The three-dimensional architecture of these molecules is often highly complex, but it can provide valuable insights into biological processes and the development of drugs. X-ray diffraction at the MX beamlines of BESSY II can be used to decipher the 3D structure of proteins. To date, more than 5000 structures have been solved at the three MX beamlines. Here, we present a review and an outlook with  Manfred Weiss, head of the research group for macromolecular crystallography. 
  • 5000th protein structure at BESSY II: Starting point for a COVID drug
    Science Highlight
    26.02.2026
    5000th protein structure at BESSY II: Starting point for a COVID drug
    Many proteins have a complex architecture that enables biological functions. Molecules can bind to specific sites on a protein and alter its function. A team at HZB has now investigated the Nsp1 protein, which plays a role in infection with the SARS-CoV-2 virus. They analysed protein crystals, previously mixed with molecules from a fragment library, and discovered a total of 21 candidates as starting points for drug development. At the same time, they also decoded the 5000th structure at BESSY II.